Treat Clinical Depression Using Antidepressants
Main Article Content
Abstract
SSRIs are chemically distinct from traditional antidepressants such as tricyclic, tetracyclic, and monoamine oxidase inhibitors, but they share the same mechanism of action in that they selectively and potently inhibit serotonin neuronal reuptake while having no or very little effect on norepinephrine, acetylcholine, and histamine neuronal reuptake. As a result, when compared to other tricyclic and tetracyclic antidepressants, these drugs have fewer sedative, anticholinergic, and cardiovascular effects. Fluroxamine, fluroxamine, sertraline, indalpine, paroxetine, alproclate, femorxetine, and choroxamine are examples of SSRI drugs.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Belmaker, R. H., & Agam, G. (2008). Major depressive disorder. New England Journal of Medicine, 358(1), 55-68.
II. World Health Organisation(2010). http://www.who.int/mental_health /management/ depression/ definition/en/
III. Rang, H.P.; Dale, M.M.; Ritter, J.M.; Moore, P.K(2006). Pharmacology, 5thed.; Reed Elsevier: New Delhi, pp 535- 549.
IV. Medline Plus, Trusted health information for you. http://www.nlm.nih.gov/medlineplus/ency/article/000945.htm (accesed 4 September 2010).
V. Lemke, T.L.; Williams, D.A.; Roche, V.F.; Zito, S.W(2008). Foye’s Principles of Medicinal Chemistry, 6th ed.; Lippincott Williams and Wilkins: New Delhi, 2008; pp 547-60.
VI. Katzung, B. G(2007). Basic and Clinical Pharmacology, 10th ed, Mc Graw Hill: London, pp 356
VII. Sullivan, P.F.; Neale, M.C.; Kendler, K.S(2000) Genetic Epidemiology of Major Depression: Review and Meta- analysis, Am. J. Psychiatry.
VIII. Unipolar Depression(2010).http://www.informatics.susx.ac.uk/research/groups/nlp/gazdar
/teach/atc/1998/web/read/index.html
IX. Taylor, M. A., & Fink, M. (2007). Melancholia: The Diagnosis, Pathophysiology, and Treatment of Depressive Illness. J Clin Psychiatry, 68(6).
X. Schatzberg, A. F. (2003). New approaches to managing psychotic depression. Journal of Clinical Psychiatry, 64(1), 19-23.
XI. Nierenberg, A. A., Alpert, J. E., Pava, J., Rosenbaum, J. F., & Fava, M. (1998). Course and treatment of atypical depression. Journal of Clinical Psychiatry, 59(18), 5-9.
XII. http://www.ehow.com/about_5075355_double-depression.html (accessed 14 July 2010)
XIII. Aldous, N.D. M.D.; Mann, A.M(1963). The Pathophysiology of Depression. Canad. Med. Ass. J., 937-43.
XIV. Healy, D(2003). The Antidepressant Era, 4th ed.; Harward University Press Paperback, pp 1.
XV. Donald, A.J(2002). Burger’s Medicinal chemistry & Drug discovery, Volume 6; 6th Edition; Published by Wiley interscience; pp 498-517.
XVI. Hardman, G.G.; Limbird, L.E(2004). Goodman & Gilman’s The Pharmacological Basis of Therapeutics; 10th ed.; Mc Graw-Hill Medical Publishing Division, pp 652-56.
XVII. Reid, I.C.; Stewart, C.A(2001). How Antidepressants Work: New Perspectives on the Pathophysiology of Depressive Disorder, Br J Psychiatry, 178, 299–303.
XVIII. Goodwin, F.K.; Jamison, K.R(1990) Manic-Depressive Illness; Ist ed.; Oxford University Press, New York. 1990, pp 11-18.
XIX. National Institute of Mental Health(2010). http://www.nimh.nih.gov/health/topics/ anxiety-disorders/index.shtml
XX. Rector, N.A.; Bartha, C.; Kitchen, K.; Katzman, M.; Richter, M(2001). A Guide for People with Obsessive- Compulsive Disorder and Their Families; 1st ed. Centre for Addiction and Mental Health, Canada, 2001, pp 2.
XXI. Pleasure, D. E. (2003). Advances in neuropathic pain. Diagnosis, mechanism and treatment recommendations. Archives of Neurology, 60, 1524-34.
XXII. Saddling, J(2003). Neuropathic Pain. Advance in Neuroscience and Rehabilitation. 3(2), 8-14.